CLINICAL_TRIALS
trial_result
· 2017-04-18
Clinical Trial Update: A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics [Phase 1]
Summary
Phase 1 safety and pharmacokinetic study of CVX-096 in adults with Type 2 diabetes mellitus has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2017-04-18